{{Infobox company |
  name   = Mylan N.V. |
  logo   = [[File:Mylan_Logo.svg|225px]] |
  type   = [[Naamloze_vennootschap|Naamloze vennootschap]] |
  traded_as      = 原NASDAQ：MYL|
  foundation     = 美國西弗吉尼亞州[[白硫磺泉镇_(西弗吉尼亚州)|白硫磺泉镇]]<br />（{{start date and age|1961}}） |
  founder        = Milan Puskar<br>Don Panoz |
  location       = [[荷蘭|荷蘭]][[阿姆斯特丹|阿姆斯特丹]] |
  key_people     = Heather Bresch（[[CEO|CEO]]）<ref name=mylanpr2012/>|
  num_employees  = 約30,000（2015）<ref name = "MylanFactSheetJune2015"/> |
  market cap     = [[美元|US$]] 150億（2013）|
  revenue        = {{increase}} [[美元|US$]] 77.2億（2014）<ref name = "MylanFactSheetJune2015"/> |
  operating_income = {{increase}} US$ 10.1億（2011）|
  net_income     = {{increase}} US$ 6.409億（2012） |
  assets         = {{increase}} US$ 115.98億（2011）|
  equity         = {{decrease}} US$ 35.04億（2011）|
  industry       = [[制葯|制葯]] |
  products       = [[非专利药|非专利药]]、特色葯、[[原料药|原料药]]|
  subsidiaries   = [[Mylan_Pharmaceuticals|Mylan Pharmaceuticals]]<br>[[Mylan_Technologies|Mylan Technologies]]<br>[[UDL_Laboratories|UDL Laboratories]]|
  homepage       = {{URL|www.mylan.com}}
 }}

'''邁蘭'''（'''Mylan N.V.'''）是曾经的一家[[非专利药|非专利药]]、特色葯、[[原料药|原料药]]生產公司，該公司創始于美國，註冊于荷蘭，運營總部則在[[英國|英國]][[赫特福德郡|赫特福德郡]][[哈特菲尔德|哈特菲尔德]]。2007年收購印度製藥公司“Matrix Laboratories Limited”和德國製藥公司“Merck KGaA”之後成爲世界第二大非專利藥生產商。<ref name = "Pittsburgh Biz Times">{{cite news|title = Mylan buys part of drug maker|date = December 30, 2013|url = http://pittsburgh.bizjournals.com/pittsburgh/stories/2006/12/18/daily19.html|publisher = [[Pittsburgh_Business_Times|Pittsburgh Business Times]]|accessdate = 2015-10-31|archive-date = 2016-09-11|archive-url = https://web.archive.org/web/20160911211811/http://pittsburgh.bizjournals.com/pittsburgh/stories/2006/12/18/daily19.html|dead-url = no}}</ref><ref name = "Medical News Today">{{cite news|title = Mylan Laboratories To Acquire Generics Business Of Merck KGaA For 4.9 Billion Euros|date = May 26, 2007|url = http://www.medicalnewstoday.com/articles/72133.php|publisher = [[Medical_News_Today|Medical News Today]]|accessdate = 2015-10-31|archive-date = 2008-02-24|archive-url = https://web.archive.org/web/20080224024857/http://www.medicalnewstoday.com/articles/72133.php|dead-url = yes}}</ref> <ref name="Pittsburgh Trib">
{{cite news|title = Pharmaceutical giants tracking Mylan's prosperity|date = August 13, 2008|url = http://www.pittsburghlive.com/x/pittsburghtrib/business/s_582510.html|publisher = [[The_Pittsburgh_Tribune-Review|The Pittsburgh Tribune-Review]]|deadurl = yes|archiveurl = https://web.archive.org/web/20080908010555/http://www.pittsburghlive.com/x/pittsburghtrib/business/s_582510.html|archivedate = 2008年9月8日}}</ref> 它在各大洲還運營有多個子公司。

2019年7月29日，邁蘭和[[輝瑞|輝瑞]]旗下的非專利藥物部門[[厄普约翰|厄普约翰]]合併，邁蘭股東將持有新公司43%股份，合併後的新公司年銷售額將超過200億美元，其產品組合包括輝瑞的陽痿藥物威而鋼、膽固醇藥片立普妥（Lipitor）、止痛藥Lyrica和Mylan的緊急過敏治療EpiPen。由邁蘭和厄普约翰合併後的新公司[[暉致|暉致]]於2020年11月16日正式成立。

==參考文獻==
{{reflist|colwidth=35em|refs=

<ref name = "MylanFactSheetJune2015">{{cite news|title=Fact Sheet|url=http://www.mylan.com/-/media/mylancom/files/company/mylanfactsheetjune2015.pdf|accessdate=2015-10-31|archive-date=2016-03-04|archive-url=https://web.archive.org/web/20160304220947/http://www.mylan.com/-/media/mylancom/files/company/mylanfactsheetjune2015.pdf|dead-url=yes}}</ref>

<ref name=mylanpr2012>{{Citation |publication-date=January 20, 2012 |accessdate=January 22, 2012 |title=Mylan Inc. (MYL) Launches Innovative Version of Antiepileptic Drug Levetiracetam |type=press release |work=[[ClinicaSpace|ClinicaSpace]] |publisher=Mylan |url=http://www.clinicaspace.com/news_story.aspx?NewsEntityId=246929 |archive-url=https://web.archive.org/web/20130116053818/http://www.clinicaspace.com/news_story.aspx?NewsEntityId=246929 |archive-date=2013-01-16 |dead-url=yes }}</ref>

}}

[[Category:美國制葯公司|Category:美國制葯公司]]
[[Category:1961年成立的公司|Category:1961年成立的公司]]